Cargando…
l-Glutamine Attenuates DSS-Induced Colitis via Induction of MAPK Phosphatase-1
Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn’s disease, is a multifactorial inflammatory disease of the small intestine and colon. Many investigators have reported that l-glutamine (Gln) therapy improves outcomes of experimental colitis models, although the mechanism i...
Autores principales: | Jeong, Soo-Yeon, Im, Yoo Na, Youm, Ji Young, Lee, Hern-Ku, Im, Suhn-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872706/ https://www.ncbi.nlm.nih.gov/pubmed/29494494 http://dx.doi.org/10.3390/nu10030288 |
Ejemplares similares
-
Glutamine up-regulates MAPK phosphatase-1 induction via activation of Ca(2+)→ ERK cascade pathway
por: Ayush, Otgonzaya, et al.
Publicado: (2016) -
Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation
por: Kim, June‐Mo, et al.
Publicado: (2021) -
Grim19 Attenuates DSS Induced Colitis in an Animal Model
por: Kim, Jae-kyung, et al.
Publicado: (2016) -
N-Acetyldopamine Dimer Attenuates DSS-Induced Ulcerative Colitis by Suppressing NF-κB and MAPK Pathways
por: Huang, Li-Jun, et al.
Publicado: (2022) -
Anti-inflammatory Effects of Gallotannin in Combination With Lactobacillus plantarum in a DSS-Induced Colitis Mouse Model
por: Kim, Hyemee, et al.
Publicado: (2022)